Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

911 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data.
Berton M, Bettonte S, Stader F, Decosterd L, Tarr PE, Livio F, Cavassini M, Braun DL, Kusejko K, Hachfeld A, Bernasconi E, Calmy A, Schmid P, Battegay M, Marzolini C; Swiss HIV Cohort Study. Berton M, et al. Among authors: battegay m. Clin Infect Dis. 2024 Jan 25;78(1):98-110. doi: 10.1093/cid/ciad495. Clin Infect Dis. 2024. PMID: 37602428 Free PMC article.
Influence of hepatitis G virus infection on liver disease.
Diamantis ID, Kouroumalis E, Koulentaki M, Fasler-Kan E, Schmid PA, Hirsch HH, Bühler H, Gyr K, Battegay M. Diamantis ID, et al. Among authors: battegay m. Eur J Clin Microbiol Infect Dis. 1997 Dec;16(12):916-9. doi: 10.1007/BF01700559. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9495673
Lamivudine for chronic hepatitis B.
Bernasconi E, Battegay M. Bernasconi E, et al. Among authors: battegay m. N Engl J Med. 1998 Dec 10;339(24):1786-7. doi: 10.1056/NEJM199812103392413. N Engl J Med. 1998. PMID: 9867557 No abstract available.
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
Furrer H, Egger M, Opravil M, Bernasconi E, Hirschel B, Battegay M, Telenti A, Vernazza PL, Rickenbach M, Flepp M, Malinverni R. Furrer H, et al. Among authors: battegay m. N Engl J Med. 1999 Apr 29;340(17):1301-6. doi: 10.1056/NEJM199904293401701. N Engl J Med. 1999. PMID: 10219064 Free article. Clinical Trial.
Rare AIDS-defining diseases in the Swiss HIV Cohort Study.
Burckhardt B, Sendi P, Pfluger D, Zimmerli W, Nüesch R, Bucher HC, Drewe J, Gyr N, Battegay M. Burckhardt B, et al. Among authors: battegay m. Eur J Clin Microbiol Infect Dis. 1999 Jun;18(6):399-402. doi: 10.1007/s100960050307. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10442416
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudine.
Sudre P, Chave JP, Ruef C, Iten A, Bucher HC, Vernazza PL, Furrer H, Bernasconi E, Ceserani N, Battegay M, Von Overbeck J, Cassis I, Lazzarin A, Gabriel V, Hirschel BJ; The Swiss HIV Cohort Study. Sudre P, et al. Among authors: battegay m. Clin Microbiol Infect. 1997 Feb;3(6):629-633. doi: 10.1111/j.1469-0691.1997.tb00469.x. Clin Microbiol Infect. 1997. PMID: 11864204 Free article.
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection.
Opravil M, Hirschel B, Lazzarin A, Furrer H, Chave JP, Yerly S, Bisset LR, Fischer M, Vernazza P, Bernasconi E, Battegay M, Ledergerber B, Günthard H, Howe C, Weber R, Perrin L; Swiss HIV Cohort Study. Opravil M, et al. Among authors: battegay m. J Infect Dis. 2002 May 1;185(9):1251-60. doi: 10.1086/340312. Epub 2002 Apr 1. J Infect Dis. 2002. PMID: 12001042 Free article. Clinical Trial.
911 results